Briggs, A., Starkie, H., and Wu, O. (2009) Health economics in asthma and COPD. In: Barnes, P.J., Drazen, J.M., Rennard, S.I. and Thomson, N.C. (eds.) Asthma and COPD. Academic Press/Elsevier,, London, pp. 751-760. ISBN 9780123740014
Full text not currently available from Enlighten.
Publisher's URL: http://dx.doi.org/10.1016/B978-0-12-374001-4.00062-6
In this chapter the reader is introduced to the methods of applying health economic evaluation methodology. A particular distinction is made between cost-of-illness studies that summarize the financial burden of disease and full economic evaluations which describe how treatments can change the both the financial and health burden of a disease. The evidence relating to cost-of-illness and full economic evaluations for both asthma and COPD is reviewed in detail. These reviews suggest that treatment patterns for both asthma and COPD have changed markedly in recent years, with a trend towards increased use of medications and to the use of combinations of medical products. The high costs of some of these treatments, in particular the newer biologic products, is likely to mean that health economic issues will become increasingly important in years to come.
|Item Type:||Book Section|
|Glasgow Author(s):||Briggs, Prof Andrew and Wu, Dr Olivia|
|Authors:||Briggs, A., Starkie, H., and Wu, O.|
|College/School:||College of Medical Veterinary and Life Sciences > School of Medicine > Centre for Population and Health Sciences|
College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Health Economics and Health Technology Assessment